3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
4
Suspended
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
2
Lung Neoplasms
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasms
1
NSCLC
1
Mesothelioma
1
Breast Neoplasms
1
Interventions
HM781-36B
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
NSCLC
×
Docetaxel
×
Clear all
NCT05378763
2026-05-22
PINNACLE
Spectrum Pharmaceuticals, Inc
Phase 3
Suspended
268 enrolled